FIRST Amendment to collaboration AND LICENSE AGREEMENTCollaboration and License Agreement • February 16th, 2021 • Nurix Therapeutics, Inc. • Pharmaceutical preparations • New York
This First Amendment to Collaboration and License Agreement (this “Amendment”) is entered into as of January 6, 2021 (the “Amendment Date”) by and between Genzyme Corporation, a Massachusetts corporation (“Sanofi”), and Nurix Therapeutics, Inc., a Delaware corporation (“Nurix”). Sanofi and Nurix are each referred to herein by name or, individually, as a “Party” or, collectively, as the “Parties.”
